Managing Drug-Seeking Patients: Q&A with Damon Raskin, MD

CATR: What about when patients ask for stimulants? How do you weed out true ADHD cases from not-so-true ones?

Dr. Raskin: Well, first of all, there’s no question stimulant medications are overprescribed, and there are a lot of people who claim they have ADHD who really don’t. When patients complain of ADHD symptoms, it’s important to ask how long they’ve had them. If they were diagnosed in childhood and they needed stimulants to get through school—and school records can tell you that—then that’s one thing. But if I have a patient that aced high school, went to Yale, and finished law school, and now just needs some Adderall to help them through a case to impress the senior partner, that’s an illegitimate use of the drug.

CATR: So how do you handle these patients?

Dr. Raskin: If I don’t think a patient has true ADHD, I’ll explain to them the hazards and side effects of stimulant medications, like insomnia, anxiety, heart palpitations, elevated blood pressure, and decreased appetite—those types of things. And I tell them that these medications don’t necessarily help patients without true ADHD. In today’s society, we’re all trying to get so much done in a day, and life is stressful. I’ll ask the patient, “Look, is this something that can be managed with changing some behaviors? Is it something that can be managed with just prioritizing?” For some patients, it may be appropriate to offer a non-stimulant medication like atomoxetine that doesn’t have any addictive properties. Or sometimes I’ll offer a patient bupropion if I think there’s an element of depression that could account for lack of concentration, focus, or motivation. But for those patients who insist they need stimulants for ADHD, but I’m not convinced, I’ll often refer them for cognitive testing.

CATR: Doctors often inherit patients who are already taking high doses or combinations of controlled substances that they’re not comfortable prescribing. How can they get those patients to accept coming back down to safe dosing levels?

Dr. Raskin: This happened to me. There was a doctor who retired a few years back in a town where I used to practice, and he just loved to prescribe big doses of narcotics. I inherited quite a few of his patients, and they were all really happy. And they were not young people looking to get high; they were 70-year-old men and women on 6 or 8 Percocet a day for back pain, fibromyalgia, headaches, and these types of things. With patients like this, I don’t just say, “Hey, I’m going to take you off these drugs” because that doesn’t help them. But I do try to explain the dangers of these drugs—the hazards of confusion, falls, car accidents, and so on. These conversations are especially important with older patients, and especially if we’re combining benzodiazepines, opiates, and other sedating medications.

CATR: That’s true. What’s your usual protocol for reducing levels?

This article originally appeared in The Carlat Addiction Treatment Report -- current coverage of topics in addiction medicine.
Want more, plus easy CME credit?
Subscribe today!

Dr. Raskin: After explaining the rationale, I’ll try to reduce the medications slowly and strategically. I might convert a shortacting narcotic to a long-acting narcotic, for example, and then try to add in some adjunctive therapy. For example, if I believe there is a legitimate pain issue, then I’ll evaluate if that patient might be a good candidate for nonsteroidal anti-inflammatory drugs. I’ll think about whether they’re a good candidate for other medications like gabapentin, pregabalin, duloxetine, or tricyclic antidepressants. These alternatives can be used to help with pain as well as facilitate reducing the narcotics. Finally, and this is extremely important, I’ll talk to patients about things they can do that don’t involve drugs, like physical therapy, meditation, and acupuncture, that have a role in treating chronic pain.

CATR: There is a new black box warning for combining benzodiazepines and opioids. Could that provide a new tool for doctors to negotiate with medication-seeking patients?

Dr. Raskin: Absolutely. It’s nice to be able to say, “You know what? This is contraindicated, and there have been some good studies to say that this is a dangerous combination, so let’s see what we can do to not have you be on this combination.” So, again, it’s a good tool to use when you’re talking to your patients.

I don’t just tell patients, ‘I’m not giving this to you.’ I want to offer them real solutions for the problem they have, and they can always come back when they are ready.
~ Damon Raskin, MD

CATR: Patients occasionally threaten doctors with legal action if they don’t get what they want. Do you have any advice for handling that situation?

Dr. Raskin: I think the best way to protect yourself as physicians is to document the conversation, including your concerns and why you are not prescribing the requested medication. That should be enough protection. After all, there is nothing that says doctors have to prescribe controlled substances just because a patient wants them.

CATR: Do you have any advice for doctors who feel beholden to patient satisfaction scores and are afraid they’ll lose revenue if they say “no” to drug-seeking patients?

Dr. Raskin: I think of the Hippocratic Oath that we take when we become doctors. It’s about patients’ best interests, not satisfaction surveys. If we continue to give patients something we feel is not in their best interests just to make them happy, then that’s not fulfilling our oath. It’s an ethical issue and a moral one. We go into medicine to help people, not to harm them. And remember, saying “no” to a drug-seeking patient doesn’t mean you’re abandoning the patient. You can still offer addiction treatment or referral to an addiction specialist.

CATR: Thanks very much for your time, Dr. Raskin.

Managing Drug-Seeking Patients: Q&A with Damon Raskin, MD

This article originally appeared in:

The Carlat Addiction Treatment Report
Click on the image to learn more or subscribe today!

This article was published in print November/December 2016 in 4:8.

The Carlat Psychiatry Report

Carlat Publishing provides clear, authoritative, engaging, independent psychiatric education to make you look forward to learning, with the goal of helping you feel smarter, more competent, and more confident in your ability to help your patients become happy. We receive no corporate funding, which allows a clear-eyed evaluation of all available treatments. Learn more and subscribe to one of their newsletters here.


APA Reference
Psychiatry Report, T. (2017). Managing Drug-Seeking Patients: Q&A with Damon Raskin, MD. Psych Central. Retrieved on February 25, 2020, from


Scientifically Reviewed
Last updated: 28 Dec 2017
Last reviewed: By John M. Grohol, Psy.D. on 28 Dec 2017
Published on All rights reserved.